
Industry News
Helio Genomics CEO Justin Chen Li Selected to Join Leadership Board of Terasaki Institute for Biomedical Innovation
Brings Expertise in Innovative Approaches to Early-Stage Cancer Detection Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for early cancer detection, is pleased to announce